Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03113474
Other study ID # NL51830.081.14
Secondary ID
Status Completed
Phase N/A
First received April 9, 2017
Last updated May 22, 2017
Start date September 15, 2015
Est. completion date October 8, 2015

Study information

Verified date May 2017
Source Wageningen University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study into the endocannabinoid response to consuming a palatable versus a neutral food.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date October 8, 2015
Est. primary completion date October 8, 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Healthy (self-report)

- Dutch

- Evaluating one of the used foods as palatable

- Evaluating one of the used foods as neutral

- Hb value between 8.1 and 11.0 mmol/L at screening

Exclusion Criteria:

- restraint eating

- lack of appetite

- difficulties eating/swallowing

- endocrine disorders

- energy restricted diet two months prior to study

- weight change > 5 kg in two months prior to study

- stomach or bowel disease

- taste or smell disorders (self-report)

- not consuming foods used in the study

- smoking > 1 cigarette per day

- drinking > 21 units alcohol per week

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Food palatability
Food palatability is modulated

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Wageningen University

Outcome

Type Measure Description Time frame Safety issue
Primary Endocannainoid levels To assess changes in endocannabinoid plasma levels prior to, during and after eating a palatable versus a neutral food prior to, during and two hours after eating
Secondary Pancreatic polypeptide (pg/ml) To assess changes in pancreatic polypeptide plasma levels prior to, during and after eating a palatable versus a neutral food prior to, during and two hours after eating
Secondary Ghrelin (pg/ml) To assess changes in ghrelin plasma levels prior to, during and after eating a palatable versus a neutral food prior to, during and two hours after eating
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2